Back
NovaBay Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
71
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$4.68
Seasonality Move:
10.47%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
NovaBay Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.05 | Buy |
| 20-day SMA: | 2.57 | Buy |
| 50-day SMA: | 1.69 | Buy |
| 200-day SMA: | 1.12 | Buy |
| 8-day EMA: | 4.13 | Buy |
| 20-day EMA: | 3.03 | Buy |
| 50-day EMA: | 1.98 | Buy |
| 200-day EMA: | 0.78 | Buy |
NovaBay Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 72.07 | Buy |
| Chaikin Money Flow: | 33023 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.78 - 3.7) | Buy |
| Bollinger Bands (100): | (0.61 - 2.67) | Buy |
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals, Inc. Stock
Is NovaBay Pharmaceuticals, Inc. Stock a Buy?
-
NovaBay Pharmaceuticals, Inc. share price is 4.75 while NBY 8-day simple moving average is 4.05, which is a Buy signal.
-
The stock price of NBY is 4.75 while NovaBay Pharmaceuticals, Inc. 20-day SMA is 2.57, which makes it a Buy.
-
NovaBay Pharmaceuticals, Inc. 50-day simple moving average is 1.69 while NBY share price is 4.75, making it a Buy technically.
-
NBY stock price is 4.75 and NovaBay Pharmaceuticals, Inc. 200-day simple moving average is 1.12, creating a Buy signal.
NBY Technical Analysis vs Fundamental Analysis
Buy
71
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy or a Sell?
-
NovaBay Pharmaceuticals, Inc. stock is rated a BuyThe current NovaBay Pharmaceuticals, Inc. [NBY] share price is $4.75. The Score for NBY is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
NovaBay Pharmaceuticals, Inc. Stock Info
Market Cap:
598.6M
Price in USD:
4.75
Share Volume:
442.5K
NovaBay Pharmaceuticals, Inc. 52-Week Range
52-Week High:
6.47
52-Week Low:
0.46
Buy
71
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
NovaBay Pharmaceuticals, Inc. Share Price Forecast
-
What is the NovaBay Pharmaceuticals, Inc. stock price today?The NovaBay Pharmaceuticals, Inc. stock price is 4.75 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals, Inc. is not overvalued.
Is NovaBay Pharmaceuticals, Inc. Stock a Buy?
-
NovaBay Pharmaceuticals, Inc. share price is 4.75 while NBY 8-day exponential moving average is 4.13, which is a Buy signal.
-
The stock price of NBY is 4.75 while NovaBay Pharmaceuticals, Inc. 20-day EMA is 3.03, which makes it a Buy.
-
NovaBay Pharmaceuticals, Inc. 50-day exponential moving average is 1.98 while NBY share price is 4.75, making it a Buy technically.
-
NBY stock price is 4.75 and NovaBay Pharmaceuticals, Inc. 200-day simple moving average is 0.78, creating a Buy signal.
Fundamental Analysis of NovaBay Pharmaceuticals, Inc.
Is NovaBay Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals, Inc.
Should I short NovaBay Pharmaceuticals, Inc. stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is 0.96, suggesting NovaBay Pharmaceuticals, Inc. is a Buy
-
NovaBay Pharmaceuticals, Inc. Relative Strength Index (RSI) is 72.07, which suggest NovaBay Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals, Inc. is (0.78 - 3.7), which suggest NovaBay Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals, Inc. is (0.61 - 2.67), which suggest NovaBay Pharmaceuticals, Inc. is a Buy
* NovaBay Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.